Goldman Sachs analyst Bonnie Herzog is incrementally more positive on Molson Coors Beverage & Constellation Brands but incrementally negative on Boston Beer Company based on feedback from the beer distributor contacts in the recent Beverage Bytes survey.
Norwegian Cruise Line Holdings unveils plans for eight new vessels, expanding its fleet with nearly 25,000 additional berths across three brands. The company also initiates construction of a multi-ship pier at Great Stirrup Cay, enhancing its Caribbean port infrastructure.
The latest findings from Alnylam Pharmaceuticals' KARDIA-2 Phase 2 study are on zilebesiran's efficacy and safety in treating hypertension. Results show significant reductions in systolic blood pressure with standard-of-care antihypertensives.
FDA approves Johnson & Johnson's Carvykti, a BCMA-targeted therapy for relapsed or refractory multiple myeloma patients, offering hope with increased manufacturing capacity and extended collaboration efforts.
ULTA faces challenging top-line comparisons in major categories, says analyst. Despite gains in mass, prestige market share affected by strong growth in 2022. Analyst lowers 1Q24 comp growth to +1.0% and FY24 comp growth to +3.8%, with reduced EBIT margin and EPS estimates.